Zach LaVine: Everything you need to know

Zach LaVine

#8 SG

Sacramento Kings

Status

OUT - Finger - Surgery Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

20.7

4.0

3.9

0.3

0.9

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	39	37	31.4	19.2	2.8	2.3	0.3	0.7	1.9	0	2.5	6.5	39.0%	4.2	7.5	55.6%	6.7	14.0	47.9%	3.2	3.6	88.0%	0.2	2.6	2.1	1.2	-310	61.4%
2024-25	74	74	35.2	23.3	4.3	4.2	0.2	0.8	2.8	6	3.2	7.2	44.6%	5.2	9.3	56.2%	8.4	16.5	51.1%	3.2	3.9	82.5%	0.3	4.0	1.6	1.5	-70	63.9%
2023-24	25	23	34.9	19.5	5.2	3.9	0.3	0.8	2.1	1	2.4	6.8	34.9%	4.4	8.3	53.6%	6.8	15.0	45.2%	3.5	4.1	85.4%	0.3	4.8	2.3	1.9	-92	57.8%
2022-23	77	77	35.9	24.8	4.5	4.2	0.2	0.9	2.5	2	2.6	7.1	37.5%	6.1	11.0	55.6%	8.7	18.0	48.5%	4.7	5.6	84.8%	0.5	3.9	2.1	1.7	+18	60.7%
2021-22	67	67	34.7	24.4	4.6	4.5	0.3	0.6	2.6	0	2.8	7.1	38.9%	5.7	10.6	53.4%	8.4	17.7	47.6%	4.8	5.6	85.3%	0.3	4.3	1.8	1.8	-26	60.5%
2020-21	58	58	35.1	27.4	5.0	4.9	0.5	0.8	3.5	3	3.4	8.2	41.9%	6.4	11.1	57.1%	9.8	19.4	50.7%	4.4	5.1	84.9%	0.6	4.4	2.4	1.4	-9	63.4%
2019-20	60	60	34.8	25.5	4.8	4.2	0.5	1.5	3.4	2	3.1	8.1	38.0%	5.9	11.9	49.7%	9.0	20.0	45.0%	4.5	5.6	80.2%	0.7	4.1	2.2	1.2	-191	56.8%
2018-19	63	62	34.5	23.7	4.7	4.5	0.4	1.0	3.4	2	1.9	5.1	37.4%	6.5	12.9	50.4%	8.4	18.0	46.7%	5.0	6.0	83.2%	0.6	4.0	2.2	1.3	-301	57.4%
2017-18	24	24	27.3	16.7	3.9	3.0	0.2	1.0	1.8	0	1.8	5.1	34.1%	3.9	9.7	40.5%	5.7	14.8	38.3%	3.6	4.5	81.3%	0.4	3.5	2.3	1.7	-172	49.9%
2016-17	47	47	38.0	18.9	3.4	3.0	0.2	0.9	1.8	0	2.6	6.6	38.7%	4.4	8.5	51.5%	6.9	15.1	45.9%	2.5	3.0	83.6%	0.4	3.0	2.2	1.6	+0	57.6%
2015-16	82	33	28.0	14.0	2.8	3.1	0.2	0.8	1.9	0	1.5	3.9	38.9%	3.8	7.8	48.2%	5.3	11.7	45.2%	2.0	2.5	79.3%	0.3	2.5	2.4	1.6	+0	54.8%
2014-15	77	40	24.7	10.1	2.8	3.6	0.1	0.7	2.5	0	0.7	2.2	34.1%	3.0	6.6	44.9%	3.7	8.8	42.2%	1.9	2.3	84.2%	0.4	2.4	2.1	1.4	+0	51.5%
Career	693	602	32.8	20.7	4.0	3.9	0.3	0.9	2.6	16	2.4	6.0	39.1%	5.0	9.7	52.0%	7.4	15.7	47.0%	3.6	4.3	83.5%	0.4	3.6	2.1	1.5	-1153	58.8%

Career Averages

PTS

REB

AST

BLK

STL

19.3

5.3

6.0

0.3

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2021-22	4	4	38.3	19.3	5.3	6.0	0.3	0.8	3.0	2	0	2.3	6.0	37.5%	4.5	9.8	46.2%	6.8	15.8	42.9%	3.5	3.8	93.3%	0.0	5.3	2.3	2.0	-41	55.3%
Career	4	4	38.3	19.3	5.3	6.0	0.3	0.8	3.0	2	0	2.3	6.0	37.5%	4.5	9.8	46.2%	6.8	15.8	42.9%	3.5	3.8	93.3%	0.0	5.3	2.3	2.0	-41	55.3%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/15	LAC	L 109-91	28	13	4	6	0	3	0	5	1	20.0%	6	5	83.3%	11	6	54.5%	0	0	0.0%	0	4	0.0	-15	3	19	59.1%
10/10	POR	L 124-123	25	19	4	2	0	1	1	8	5	62.5%	3	2	66.7%	11	7	63.6%	0	0	0.0%	0	4	2.0	+12	2	19	86.4%
10/8	TOR	L 130-122	14	16	1	1	0	0	1	5	3	60.0%	2	2	100.0%	7	5	71.4%	3	3	100.0%	1	0	1.0	+5	0	18	96.2%
Preseason Totals			22.8	16.0	3.0	3.0	0.0	1.3	0.7	6.0	3.0	50.0%	3.7	3.0	81.8%	9.7	6.0	62.1%	1.0	1.0	100.0%	0.3	2.7	4.5	+2	1.7	20.7	79.2%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
2/6	LAC	L 114-111	18	6	2	4	1	1	0	3	0	0.0%	3	2	66.7%	6	2	33.3%	2	2	100.0%	0	2	0.0	-9	1	9	43.6%
2/4	MEM	L 129-125	22	11	1	0	0	1	1	3	1	33.3%	6	2	33.3%	9	3	33.3%	4	4	100.0%	1	0	0.0	-13	2	8	51.1%
2/1	WAS	L 116-112	35	35	6	2	0	1	2	10	4	40.0%	16	9	56.3%	26	13	50.0%	5	5	100.0%	0	6	1.0	-8	1	31	62.1%
1/30	BOS	L 112-93	23	17	4	1	0	0	1	4	1	25.0%	5	4	80.0%	9	5	55.6%	7	6	85.7%	1	3	1.0	-28	1	19	70.4%
1/29	PHI	L 113-111	28	17	1	3	0	2	3	6	2	33.3%	10	3	30.0%	16	5	31.3%	5	5	100.0%	0	1	1.0	-3	3	8	46.7%
1/23	CLE	L 123-118	22	10	0	0	0	1	1	5	2	40.0%	3	2	66.7%	8	4	50.0%	0	0	0.0%	0	0	0.0	-20	2	4	62.5%
1/21	TOR	L 122-109	37	19	1	5	1	1	2	8	2	25.0%	9	5	55.6%	17	7	41.2%	4	3	75.0%	0	1	2.5	-14	2	16	50.6%
1/20	MIA	L 130-117	22	18	1	5	0	0	1	4	3	75.0%	6	4	66.7%	10	7	70.0%	2	1	50.0%	0	1	5.0	-3	2	18	82.7%
1/18	POR	L 117-110	28	18	0	1	0	1	1	8	3	37.5%	5	2	40.0%	13	5	38.5%	6	5	83.3%	0	0	1.0	-7	2	9	57.5%
1/16	WAS	W 128-115	32	16	2	3	2	1	0	6	3	50.0%	6	3	50.0%	12	6	50.0%	2	1	50.0%	0	2	0.0	+10	3	15	62.1%
1/14	NYK	W 112-101	36	25	5	1	0	0	3	9	5	55.6%	5	3	60.0%	14	8	57.1%	4	4	100.0%	0	5	0.3	+16	4	22	79.3%
1/12	LAL	W 124-112	31	19	4	1	1	0	1	4	3	75.0%	7	3	42.9%	11	6	54.5%	4	4	100.0%	0	4	1.0	+9	0	20	74.5%
1/11	HOU	W 111-98	27	18	2	1	0	0	3	6	3	50.0%	5	2	40.0%	11	5	45.5%	6	5	83.3%	0	2	0.3	-1	3	11	66.0%
1/9	GSW	L 137-103	30	15	3	3	0	0	2	7	1	14.3%	8	6	75.0%	15	7	46.7%	0	0	0.0%	0	3	1.5	-29	2	10	50.0%
1/6	DAL	L 100-98	37	20	4	3	1	2	2	6	2	33.3%	13	6	46.2%	19	8	42.1%	2	2	100.0%	0	4	1.5	+3	2	15	50.3%
1/4	MIL	L 115-98	35	20	3	4	0	0	0	4	2	50.0%	8	4	50.0%	12	6	50.0%	6	6	100.0%	0	3	0.0	-6	1	21	68.3%
12/14	MIN	L 117-103	15	10	1	1	0	0	2	4	1	25.0%	4	3	75.0%	8	4	50.0%	1	1	100.0%	0	1	0.5	+6	1	6	59.2%
12/8	IND	L 116-105	38	16	2	3	0	1	5	6	2	33.3%	7	4	57.1%	13	6	46.2%	2	2	100.0%	0	2	0.6	-10	0	11	57.6%
12/6	MIA	W 127-111	39	42	5	1	0	1	0	13	8	61.5%	11	4	36.4%	24	12	50.0%	11	10	90.9%	0	5	0.0	+15	3	38	72.8%
12/3	HOU	L 121-95	18	2	1	1	2	1	1	3	0	0.0%	2	1	50.0%	5	1	20.0%	0	0	0.0%	1	0	1.0	+6	1	0	20.0%
11/30	MEM	L 115-107	35	19	3	3	0	2	0	6	2	33.3%	11	6	54.5%	17	8	47.1%	2	1	50.0%	1	2	0.0	-30	1	16	53.1%
11/28	UTA	L 128-119	38	34	2	6	0	0	2	9	4	44.4%	14	8	57.1%	23	12	52.2%	9	6	66.7%	0	2	3.0	+18	5	25	63.1%
11/26	PHX	L 112-100	31	13	2	2	0	1	6	6	1	16.7%	8	4	50.0%	14	5	35.7%	2	2	100.0%	1	1	0.3	-4	2	3	43.7%
11/24	MIN	W 117-112	31	7	3	1	0	1	1	6	1	16.7%	4	2	50.0%	10	3	30.0%	0	0	0.0%	0	3	1.0	-4	3	0	35.0%
11/22	DEN	W 128-123	35	15	2	3	0	2	2	6	1	16.7%	8	5	62.5%	14	6	42.9%	2	2	100.0%	0	2	1.5	-6	1	12	50.4%
11/20	MEM	L 137-96	26	26	2	2	0	1	3	8	4	50.0%	9	6	66.7%	17	10	58.8%	2	2	100.0%	0	2	0.7	-22	2	20	72.7%
11/19	OKC	L 113-99	30	8	4	2	0	0	5	4	0	0.0%	6	4	66.7%	10	4	40.0%	0	0	0.0%	1	3	0.4	-16	1	2	40.0%
11/16	SAS	L 123-110	24	8	2	3	0	1	2	4	1	25.0%	3	2	66.7%	7	3	42.9%	1	1	100.0%	0	2	1.5	-7	2	7	53.8%
11/14	MIN	L 124-110	36	25	6	3	1	1	4	8	4	50.0%	9	4	44.4%	17	8	47.1%	5	5	100.0%	0	6	0.8	-18	4	22	65.1%
11/11	DEN	L 122-108	34	12	4	3	0	0	1	6	2	33.3%	6	3	50.0%	12	5	41.7%	2	0	0.0%	0	4	3.0	-22	2	8	46.6%
11/9	MIN	L 144-117	29	26	4	2	0	1	1	9	6	66.7%	8	4	50.0%	17	10	58.8%	0	0	0.0%	1	3	2.0	-21	2	22	76.5%
11/7	OKC	L 132-101	28	9	2	2	0	1	2	3	2	66.7%	2	1	50.0%	5	3	60.0%	2	1	50.0%	0	2	1.0	-24	3	7	76.5%
11/3	DEN	L 130-124	36	15	5	4	0	0	3	5	1	20.0%	6	3	50.0%	11	4	36.4%	7	6	85.7%	0	5	1.3	-14	6	11	53.3%
11/1	MIL	W 135-133	38	31	4	2	0	1	0	13	6	46.2%	4	2	50.0%	17	8	47.1%	10	9	90.0%	0	4	0.0	-4	2	30	72.4%
10/29	CHI	L 126-113	36	30	3	3	0	2	2	8	2	25.0%	11	10	90.9%	19	12	63.2%	4	4	100.0%	0	3	1.5	-23	1	32	72.3%
10/28	OKC	L 107-101	35	23	4	3	0	0	4	6	4	66.7%	7	2	28.6%	13	6	46.2%	7	7	100.0%	0	4	0.8	-15	1	20	71.5%
10/26	LAL	L 127-120	39	32	4	0	0	0	2	9	4	44.4%	15	8	53.3%	24	12	50.0%	4	4	100.0%	1	3	0.0	-8	1	22	62.1%
10/24	UTA	W 105-104	37	31	2	1	1	0	1	9	4	44.4%	9	6	66.7%	18	10	55.6%	7	7	100.0%	0	2	1.0	+2	3	29	73.5%
10/22	PHX	L 120-116	34	30	2	1	0	0	2	10	2	20.0%	14	11	78.6%	24	13	54.2%	3	2	66.7%	0	2	0.5	-6	3	19	59.2%
Regular Season Totals			31.4	19.2	2.8	2.3	0.3	0.7	1.9	6.5	2.5	39.0%	7.5	4.2	55.6%	14.0	6.7	47.9%	3.6	3.2	88.0%	0.2	2.6	1.2	-310	2.1	18.1	61.4%

Zach LaVine: Breaking News

LaVine will undergo season-ending surgery on his right hand after the All-Star break, Chris Haynes of NBA TV reports. After missing Sacramento's final three outings before the All-Star break due to right finger soreness, LaVine is scheduled to undergo season-ending hand surgery. The veteran swingman will finish the 2025-26 season with averages of 19.2 points, 2.8 rebounds and 2.3 assists while shooting 47.9 percent from the field and 39.0 percent from downtown across 31.4 minutes per contest in 39 regular-season games (37 starts). He holds a $48.97 million player option for the 2026-27 campaign. With LaVine sidelined, Nique Clifford should continue to see an expanded role, while Malik Monk (illness) and Devin Carter are also candidates for increased playing time.

LaVine (finger) is out for Wednesday's game against the Jazz. LaVine will miss a third straight game due to finger soreness. His next chance to play won't come until after the All-Star break, so he'll have over a week to rest and recover. In the meantime, look for Nique Clifford and Devin Carter to see more minutes.

LaVine (finger) has been ruled out for Monday's game against the Pelicans. LaVine will be sidelined for a second consecutive game due to right finger soreness, and his last opportunity to suit up before the All-Star break is Wednesday against the Jazz. Nique Clifford and Devin Carter should see more minutes in LaVine's absence.